Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease andor diabetes.模式和患者降脂治疗动脉粥样硬化性心血管疾病的预测和或糖尿病人英文精品课件.pdf

Received: 9 June 2016 Revised: 29 September 2016 Accepted: 9 October 2016 DOI 10.1002/clc.22641 C L I N I C A L I N V E S T I G A T I O N S Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population Dylan L. Steen1 | Irfan Khan2 | Laura Becker3 | JoAnne M. Foody4 | Katherine Gorcyca2 | Robert J. Sanchez5 | Robert P. Giugliano6 1Division of Cardiovascular Health and Disease, University of Cincinnati Medical Background: Lowering low-density lipoprotein cholesterol with statins reduces risk of cardio- Center, Cincinnati, Ohio vascular events. We examined patterns and predictors of filled prescriptions for lipid-lowering 2Global Health Economics and Outcomes therapy (LLT) in subgroups of patients with atherosclerotic cardiovascular disease (ASCVD) Research, Sanofi, Bridgewater, New Jersey and/or diabetes mellitus (DM). 3Health Economics and Outcomes Research, Hypothesis: Statin treatment remains underutilized across subgroups of high CV risk patients. Optum, Eden Prairie, Minnesota 4 Methods: Patients in the Optum Research Database with these criteria were included: age Formerly of: Cardiovascular Division, Brigham and Women’s Hospital, Boston, ≥20 years, 2 years continuous enrollment, and ASCVD and/or DM. Patients were hierarchically Massachusetts classified by the presence of recent acute coronary syndrome, other coronary heart disease, 5Health Economics and Outcomes Research, ischemic stroke, peripheral arteri